HomeTrialNCT06302348
🔬NCT06302348Phase 3RECRUITING

A Study of Sepiapterin in Participants With Phenylketonuria (PKU)

Study Summary

The main purpose of this trial is to evaluate the long-term efficacy of sepiapterin on preserving neurocognitive functioning in children with PKU when treatment is initiated in early childhood.

Conditions
Interventions / Drugs
View on ClinicalTrials.gov ↗
Study Details
Enrollment56 participants
Primary Completion
Lead SponsorPTC Therapeutics
Data Retrieved2026-04-11 04:25:04.378893+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.